Tech Company Inital Public Offerings
Vital Therapies IPO
On 4/16/2014, Vital Therapies completed its IPO
Transaction Overview
Company Name
Announced On
4/16/2014
Transaction Type
IPO
Amount
$54,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
15010 Ave. of Science 200
San Diego, CA 92128
USA
San Diego, CA 92128
USA
Phone
Website
Email Address
Overview
Vital Therapies, Inc. (NASDAQ: VTL) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient's liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Cox
Chief Financial Officer
Michael Swanson
Chief Technical Officer
Robert Ashley
President
Duane Nash
Browse more venture capital transactions:
Prev: 4/16/2014: Paperless Post venture capital transaction
Next: 4/16/2014: Iconic Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs